157 related articles for article (PubMed ID: 7884917)
1. The human immunodeficiency virus type 1 Tat antagonist, Ro 5-3335, predominantly inhibits transcription initiation from the viral promoter.
Cupelli LA; Hsu MC
J Virol; 1995 Apr; 69(4):2640-3. PubMed ID: 7884917
[TBL] [Abstract][Full Text] [Related]
2. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of an HIV-1 Tat antagonist.
Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
Biochem Soc Trans; 1992 May; 20(2):525-31. PubMed ID: 1397654
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist.
Hsu MC; Schutt AD; Holly M; Slice LW; Sherman MI; Richman DD; Potash MJ; Volsky DJ
Science; 1991 Dec; 254(5039):1799-802. PubMed ID: 1763331
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.
Hsu MC; Dhingra U; Earley JV; Holly M; Keith D; Nalin CM; Richou AR; Schutt AD; Tam SY; Potash MJ
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6395-9. PubMed ID: 8341644
[TBL] [Abstract][Full Text] [Related]
6. A Tat antagonist inhibits HIV-1 induction in naturally infected and experimentally infected T cells.
Potash MJ; Bentsman G; McKinley G; Volsky DJ
Biochem Biophys Res Commun; 1992 Nov; 189(1):250-6. PubMed ID: 1449479
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
8. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M; Mathews MB
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
[TBL] [Abstract][Full Text] [Related]
9. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
11. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
Jeyaseelan R; Kurabayashi M; Kedes L
AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
[TBL] [Abstract][Full Text] [Related]
13. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
Laspia MF; Rice AP; Mathews MB
Genes Dev; 1990 Dec; 4(12B):2397-408. PubMed ID: 2149119
[TBL] [Abstract][Full Text] [Related]
14. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.
Chowdhury M; Taylor JP; Chang CF; Rappaport J; Khalili K
J Virol; 1992 Dec; 66(12):7355-61. PubMed ID: 1331525
[TBL] [Abstract][Full Text] [Related]
15. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus.
Koken SE; van Wamel J; Berkhout B
Gene; 1994 Jul; 144(2):243-7. PubMed ID: 8039709
[TBL] [Abstract][Full Text] [Related]
16. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
Rittner K; Churcher MJ; Gait MJ; Karn J
J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro.
Bohan CA; Kashanchi F; Ensoli B; Buonaguro L; Boris-Lawrie KA; Brady JN
Gene Expr; 1992; 2(4):391-407. PubMed ID: 1282057
[TBL] [Abstract][Full Text] [Related]
18. Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency.
Drysdale CM; Pavlakis GN
J Virol; 1991 Jun; 65(6):3044-51. PubMed ID: 2033665
[TBL] [Abstract][Full Text] [Related]
19. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
Biswas DK; Ahlers CM; Dezube BJ; Pardee AB
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
